← Back to directory

Øystein Bruserud

Researcher Next ID · RN-038457

Researcher · Biochemistry, Genetics and Molecular Biology

Haukeland University Hospital

Bergen, Norway

Accepting doctoral researchersFunding unknown
Works count
413
Citation count
10,766
H-index
52
i10-index
266

Research interests

Biochemistry, Genetics and Molecular Biology
Immunology and Microbiology
Medicine
Acute Myeloid Leukemia Research
Hematopoietic Stem Cell Transplantation
Histone Deacetylase Inhibitors Research
Immune Cell Function and Interaction
Retinoids in leukemia and cellular processes

Publications

  • Mesenchymal Stem Cells Support Survival and Proliferation of Primary Human Acute Myeloid Leukemia Cells through Heterogeneous Molecular Mechanisms

    Frontiers in Immunology · 2017 · 10.3389/fimmu.2017.00106

  • Co-transplantation of multipotent mesenchymal stromal cells in allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis

    Cytotherapy · 2016 · 10.1016/j.jcyt.2015.11.010

  • Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome

    OncoImmunology · 2015 · 10.1080/2162402x.2015.1062208

  • Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia

    Leukemia · 2014 · 10.1038/leu.2014.89

  • Therapeutic Targeting the Cell Division Cycle 25 (CDC25) Phosphatases in Human Acute Myeloid Leukemia — The Possibility to Target Several Kinases through Inhibition of the Various CDC25 Isoforms

    Molecules · 2014 · 10.3390/molecules191118414

  • SIRT1 Activation by a c-MYC Oncogenic Network Promotes the Maintenance and Drug Resistance of Human FLT3-ITD Acute Myeloid Leukemia Stem Cells

    Cell stem cell · 2014 · 10.1016/j.stem.2014.08.001

  • Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents

    Clinical Epigenetics · 2013 · 10.1186/1868-7083-5-12

  • The role of arginine and arginine-metabolizing enzymes during Giardia – host cell interactions in vitro

    BMC Microbiology · 2013 · 10.1186/1471-2180-13-256

  • Acute Myeloid Leukemia with the t(8;21) Translocation: Clinical Consequences and Biological Implications

    BioMed Research International · 2011 · 10.1155/2011/104631

  • Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cells

    BMC Immunology · 2010 · 10.1186/1471-2172-11-38

  • The Crosstalk Between the Matrix Metalloprotease System and the Chemokine Network in Acute Myeloid Leukemia

    Current Medicinal Chemistry · 2010 · 10.2174/092986710794183033

  • The proteasome inhibitors bortezomib and PR‐171 have antiproliferative and proapoptotic effects on primary human acute myeloid leukaemia cells

    British Journal of Haematology · 2007 · 10.1111/j.1365-2141.2007.06504.x

  • Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells

    Haematologica · 2007 · 10.3324/haematol.10148

  • Histone Deacetylase Inhibitors in Cancer Treatment: A Review of the Clinical Toxicity and the Modulation of Gene Expression in Cancer Cells

    Current Pharmaceutical Biotechnology · 2007 · 10.2174/138920107783018417

  • In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma‐irradiated single‐donor platelet concentrates during long‐term storage

    Transfusion · 2007 · 10.1111/j.1537-2995.2007.01167.x

  • Flt3 Y591 duplication and Bcl-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53

    Blood · 2006 · 10.1182/blood-2006-02-004234

  • A phase II trial of pegylated interferon α‐2b therapy for polycythemia vera and essential thrombocythemia

    Cancer · 2006 · 10.1002/cncr.21900

  • A Distinct p53 Protein Isoform Signature Reflects the Onset of Induction Chemotherapy for Acute Myeloid Leukemia

    Clinical Cancer Research · 2006 · 10.1158/1078-0432.ccr-05-1970

  • Microvascular endothelial cells increase proliferation and inhibit apoptosis of native human acute myelogenous leukemia blasts

    International Journal of Cancer · 2006 · 10.1002/ijc.22180

  • Animal models of acute myelogenous leukaemia – development, application and future perspectives

    Leukemia · 2005 · 10.1038/sj.leu.2403670

  • Single Cell Profiling of Potentiated Phospho-Protein Networks in Cancer Cells

    Cell · 2004 · https://doi.org/10.1016/j.cell.2004.06.028

  • Osteoblasts increase proliferation and release of pro-angiogenic interleukin 8 by native human acute myelogenous leukemia blasts.

    PubMed · 2004

  • Flt3-mediated signaling in human acute myelogenous leukemia (AML) blasts: a functional characterization of Flt3-ligand effects in AML cell populations with and without genetic Flt3 abnormalities.

    PubMed · 2003

  • Cryopreserving human peripheral blood progenitor cells with 5‐percent rather than 10‐percent DMSO results in less apoptosis and necrosis in CD34+ cells

    Transfusion · 2002 · 10.1046/j.1537-2995.2002.00242.x

  • New Strategies in the Treatment of Acute Myelogenous Leukemia (AML): In Vitro Culture of AML Cells—The Present Use in Experimental Studies and the Possible Importance for Future Therapeutic Approaches

    Stem Cells · 2001 · 10.1634/stemcells.19-1-1

Current projects

    No projects listed.